Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00762
|
|||||
| Drug Name |
GSK189254A
|
|||||
| Synonyms |
5T4TX6CO53; 6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide; 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide; 720690-73-3; 854485-15-7; ABP000814; AKOS032944981; AOB87474; BCP9000737; BDBM50247054; CHEMBL517140; CS-6206; EX-A1905; GSK 189254A; GSK-189,254; GSK-189254; GSK-189254A; GSK189254; GSK189254A; HY-14111; KB-77605; SCHEMBL169579; UNII-5T4TX6CO53; WROHEWWOCPRMIA-UHFFFAOYSA-N; ZINC3961799
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H25N3O2
|
|||||
| Canonical SMILES |
CNC(=O)C1=CN=C(C=C1)OC2=CC3=C(CCN(CC3)C4CCC4)C=C2
|
|||||
| InChI |
InChI=1S/C21H25N3O2/c1-22-21(25)17-6-8-20(23-14-17)26-19-7-5-15-9-11-24(18-3-2-4-18)12-10-16(15)13-19/h5-8,13-14,18H,2-4,9-12H2,1H3,(H,22,25)
|
|||||
| InChIKey |
WROHEWWOCPRMIA-UHFFFAOYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 351.4 | Topological Polar Surface Area | 54.5 | ||
| Heavy Atom Count | 26 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3.2
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.